Stock AVIR ATEA PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Atea Pharmaceuticals, Inc.

Equities

AVIR

US04683R1068

Market Closed - Nasdaq
Other stock markets
 01:30:00 02/05/2024 am IST 		5-day change 1st Jan Change
3.85 USD +4.05% Intraday chart for Atea Pharmaceuticals, Inc. +4.05% +26.23%
27/03 Atea Pharmaceuticals, Inc. Completes Patient Enrollment in Global Phase 3 Sunrise-3 Trial Evaluating Oral Antiviral Bemnifosbuvir for COVID-19 in High-Risk Patients CI
28/02 Atea Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ATEA PHARMACEUTICALS, INC.
Bio Therapeutic Drugs
+4.05%+4.05%+26.23%+18.10% - 312M
Bearish
Bullish
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. AVIR Stock
  4. Charts Atea Pharmaceuticals, Inc.
  5. Comparison Chart